Edition:
United States

Ion Beam Applications SA (IBAB.BR)

IBAB.BR on Brussels Stock Exchange

24.50EUR
12 Dec 2017
Change (% chg)

€0.44 (+1.85%)
Prev Close
€24.05
Open
€24.00
Day's High
€24.60
Day's Low
€23.62
Volume
133,067
Avg. Vol
131,337
52-wk High
€56.94
52-wk Low
€19.80

Latest Key Developments (Source: Significant Developments)

IBA 9-month revenues at 217.3 million euros, down 3.6% ‍​
Thursday, 16 Nov 2017 12:46am EST 

Nov 16 (Reuters) - ION BEAM APPLICATIONS SA ::9M REVENUES TO 30 SEPTEMBER 2017 OF EUR 217.3 MILLION, DOWN 3.6% ‍​.‍PROTON THERAPY AND OTHER ACCELERATORS ORDERS AT END OF Q3 TOTALLING EUR 76.7 MILLION​.EXPECTS FY17: 5-10% REVENUE GROWTH AND A 0-5% REBIT MARGIN.EXPECTS 2018/2019: 0-5% REVENUE GROWTH AND A 5-10% REBIT MARGIN.EXPECTS 2020 ONWARDS: 5-10% REVENUE GROWTH AND 13-15% REBIT MARGIN..DIVIDEND POLICY REMAINS UNCHANGED..‍REITERATES ITS GUIDANCE GIVEN AT TIME OF ITS HALF YEAR 2017 RESULTS​.DOSIMETRY BACKLOG AT END OF Q3 2017 WAS AT EUR 15.4 MILLION.DOSIMETRY ORDER INTAKE REMAINED STRONG AT EUR 39.4 MILLION AT END OF Q3 2017.NET NEGATIVE CASH POSITION OF EUR 2.5 MILLION AT END OF Q3 VERSUS POSITIVE NET CASH POSITION OF EUR 36.1 MILLION YEAR AGO‍​.  Full Article

IBA and Beaumont Hospital's Cancer Institute in Michigan announce partnership
Monday, 25 Sep 2017 12:19pm EDT 

Sept 25 (Reuters) - ION BEAM APPLICATIONS SA ::‍IBA AND BEAUMONT HOSPITAL'S CANCER INSTITUTE IN ROYAL OAK, MICHIGAN ANNOUNCE PARTNERSHIP TO DEVELOP NEXT GENERATION PROTON THERAPY DELIVERY TECHNIQUE​.  Full Article

IBA and Elekta enter MOU regarding comprehensive partnership
Monday, 25 Sep 2017 02:27am EDT 

Sept 25 (Reuters) - ION BEAM APPLICATIONS SA ::ANNOUNCED ON SATURDAY IBA AND ELEKTA ENTERED A MEMORANDUM OF UNDERSTANDING (MOU)REGARDING A COMPREHENSIVE PARTNERSHIP INCLUDING JOINT SOFTWARE DEVELOPMENT AND SALES TO ADVANCE PROTON THERAPY TREATMENTS.  Full Article

IBA says it has been approached by major players in building industry - conf call‍​
Thursday, 24 Aug 2017 09:52am EDT 

Aug 24 (Reuters) - ION BEAM APPLICATIONS SA ::SAYS IT HAS BEEN APPROACHED BY MAJOR PLAYERS IN BUILDING INDUSTRY - CONF CALL‍​.SAYS IT IS WORKING ON HOW TO STANDARDISE AND HAVE MORE PREDICTABLE TIMELINE FOR PROTEUS ONE- CONF CALL‍​.SAYS WORKING CAPITAL COULD DETERIORATE SLIGHTLY - CONF CALL‍​.  Full Article

IBA H1 REBIT falls to 1.9 million euros
Thursday, 24 Aug 2017 01:00am EDT 

Aug 24 (Reuters) - ION BEAM APPLICATIONS SA ::H1 REBIT EUR 1.9​ MILLION VERSUS EUR 15.1 MILLION YEAR AGO.H1 REVENUES EUR 151.6‍​ MILLION VERSUS EUR 145.1 MILLION YEAR AGO.H1 NET LOSS EUR 4.7‍​ MILLION VERSUS PROFIT OF EUR 8.3 MILLION YEAR AGO.GUIDANCE UPDATED TO: FOR FY SEES 5-10 PERCENT REVENUE GROWTH, LOW TO MID-SINGLE DIGIT REBIT MARGIN.GUIDANCE UPDATED TO: IN 2018/2019 SEES FLAT TO MID-SINGLE DIGIT REVENUE GROWTH AND MID TO HIGH SINGLE DIGIT REBIT MARGIN.GUIDANCE UPDATED TO: IN MID-TERM SEES HIGH SINGLE-DIGIT TO LOW DOUBLE-DIGIT REVENUE GROWTH AND 13 TO 15 PERCENT REBIT MARGIN.DIVIDEND POLICY REMAINS UNCHANGED.OVER EUR 1 BILLION BACKLOG IN EQUIPMENT AND SERVICES EXPECTED TO BE CONVERTED OVER NEXT 10 YEARS.  Full Article

Ion Beam Applications sees 5-10 pct revenue growth for FY
Wednesday, 5 Jul 2017 12:59am EDT 

July 5 (Reuters) - ION BEAM APPLICATIONS SA ::COMPANY HAS A COMBINED BACKLOG OF FUTURE PROJECT REVENUES IN SERVICE AND EQUIPMENT WORTH ALMOST EUR 1 BILLION.NOW EXPECTS TO REPORT 5-10% REVENUE GROWTH AND A LOW TO MID-SINGLE DIGIT OPERATING MARGIN FOR THE H1 2017 AS WELL AS FOR FY 2017‍​.STILL ASSESSING IMPACT OF DELAYS ON 2018/2019 AND AN UPDATE WILL BE GIVEN AT TIME OF COMPANY'S HALF YEAR RESULTS.COMPANY'S DIVIDEND POLICY REMAINS UNCHANGED..REMAINS CONFIDENT ON ITS PREVIOUS TARGET OF 13 TO 15% REBIT IN THE MID-TERM.DELAYS IN PROJECT EXECUTION ARE NOW BEING EXPERIENCED IN APPROXIMATELY HALF OF ONGOING PROTON THERAPY PROJECTS.DELAYS IN PROJECT EXECUTION BY SEVERAL OF ITS CUSTOMERS HAVE CONTINUED‍​.  Full Article

Ion Beam Applications to install Africa's first proton therapy center
Friday, 28 Apr 2017 01:00am EDT 

April 28 (Reuters) - Ion Beam Applications SA ::To install Africa's first proton therapy center.The typical end-user price for a proteus one system with a maintenance contract is between EUR 35-40 million ($32.6-43.5 million).Contract signed with children's cancer hospital foundation egypt to install a proteus one solution in Cairo, Egypt.  Full Article

IBA FY REBITDA up 26.6 pct at 42.7 mln euros
Thursday, 23 Mar 2017 02:07am EDT 

Ion Beam Applications SA : Reports FY revenue 328.8 million euros ($354.8 million) versus 270.4 million euros a year ago . FY REBITDA is ‍​42.7 million euros versus 33.7 million euros a year ago . FY net result is 24.4‍​ million euros versus 61.2 million euros a year ago . Will propose dividend of 0.29 euros per share . Net cash and cash equivalents at end of year 74.6‍​ million euros versus 81.7 million euros a year ago . Revenue growth guidance maintained at around 15 pct to 20 pct in 2017 and double digit thereafter . Sees REBIT margin guidance of approx. 11 percent to 12 percent in 2017; increasing to 13-15 pct in 2018 and stabilizing at 15 pct by 2020 .30 percent dividend pay-out ratio target maintained for 2017.  Full Article

IBA selected to install new proton therapy center in Charleroi, Belgium
Monday, 20 Feb 2017 01:00am EST 

Ion Beam Applications SA : IBA selected to install new proton therapy center in Charleroi, Belgium .Wallonia region will invest a total of 47 million euros in this research project.  Full Article

IBA signs contract to install Proteus One compact proton therapy center in Abu Dhabi
Tuesday, 27 Sep 2016 01:00am EDT 

Ion Beam Applications SA :Signs contract to install Proteus One compact proton therapy center in Abu Dhabi, UAE.  Full Article